Behavioral Finance
April 23, 2026
The Debt-to-Equity Ratio is the single most important leverage filter every Indian value investor must master. Titan Biotech FY25's ₹3 Cr borrowings against a strong net worth produces a sub-0.05x D/E — a textbook illustration of a fortress balance sheet.
April 23, 2026
Charlie Munger's favourite mental model — invert the question. Instead of 'how do I find the next multibagger?', ask 'how do I guarantee small-cap losses?' A disciplined Indian inversion checklist, illustrated by Titan Biotech's FY25 audited numbers.
April 22, 2026
Richard Thaler (1980) and Kahneman-Knetsch-Thaler (1990) explain why Indian retail investors cling to inherited, IPO-allotted, and COVID-era holdings. SEBI, NSE and IIM Bangalore data + a six-step de-biasing checklist from Graham/Buffett/Munger/Klarman, with Titan Biotech (BSE:524717) FY25 audited numbers as the illustrative anti-endowment corporate case study.
April 21, 2026
Hindsight bias — Fischhoff's 'I-knew-it-all-along' effect — silently corrupts the Indian retail investor's feedback loop. Here's the academic source, the SEBI/IIM-B evidence, the decision-journal counter-measure, and a numbers-rich positive illustrative case from Titan Biotech's FY25 audited filings.
